912.00 -63.05 (-6.47%)
- 1D
- 5D
- 1M
- 6M
- 1Y
- 5Y
Price Range
Today’s Low
892.0
Today’s High
990.0
52 Week Low
957.45
52 Week High
2193.8
908.45 -69.10 (-7.07%)
- 1D
- 5D
- 1M
- 6M
- 1Y
- 5Y
Price Range
Today’s Low
890
Today’s High
994
52 Week Low
961.15
52 Week High
2199.9
Key Metrics
- Market Cap (In Cr) 3818.58
- Beta 0.79
- Div. Yield (%) 0.2
- P/B 4.7
- TTM P/E 67.66
- Peg Ratio -1.17
- Sector P/E 13.54
- D/E -
- Open Price 973.5
- Prev Close 975.05
Analysis
Price Analysis
-
1 Week-3.89%
-
3 Months-26.97%
-
6 Month-21.99%
-
YTD-14.5%
-
1 Year-51.47%
Risk Meter
- 34% Low risk
- 34% Moderate risk
- 34% Balanced Risk
- 34% High risk
- 34% Extreme risk
Recos
1 Analysts
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- Strong Sell
- 0
- Sell
- 0
- Hold
- 0
- Buy
- 1
- Strong Buy
- 0
Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2022
- Total Revenue
- 1403.72
- Selling/ General/ Admin Expenses Total
- 259.73
- Depreciation/ Amortization
- 74.66
- Other Operating Expenses Total
- 8.55
- Total Operating Expense
- 1279.25
- Operating Income
- 124.47
- Net Income Before Taxes
- 132.75
- Net Income
- 97.38
- Diluted Normalized EPS
- 23.93
- Period
- 2022
- Total Assets
- 2176.03
- Total Liabilities
- 1363.77
- Total Equity
- 812.26
- Tangible Book Valueper Share Common Eq
- 204.19
- Period
- 2022
- Cashfrom Operating Activities
- 4.74
- Cashfrom Investing Activities
- -320.45
- Cashfrom Financing Activities
- 332.91
- Net Changein Cash
- 17.07
- Period
- 2021
- Total Revenue
- 1276.56
- Selling/ General/ Admin Expenses Total
- 228.19
- Depreciation/ Amortization
- 71
- Other Operating Expenses Total
- 11.06
- Total Operating Expense
- 1116.89
- Operating Income
- 159.67
- Net Income Before Taxes
- 158.22
- Net Income
- 116.9
- Diluted Normalized EPS
- 25.56
- Period
- 2021
- Total Assets
- 1540.21
- Total Liabilities
- 817.69
- Total Equity
- 722.52
- Tangible Book Valueper Share Common Eq
- 183.1
- Period
- 2021
- Cashfrom Operating Activities
- 172.1
- Cashfrom Investing Activities
- -241.52
- Cashfrom Financing Activities
- 0.15
- Net Changein Cash
- -69.26
- Period
- 2020
- Total Revenue
- 1324.11
- Selling/ General/ Admin Expenses Total
- 65.03
- Depreciation/ Amortization
- 56.77
- Other Operating Expenses Total
- 238.79
- Total Operating Expense
- 1123.73
- Operating Income
- 200.38
- Net Income Before Taxes
- 192.63
- Net Income
- 146.03
- Diluted Normalized EPS
- 29.74
- Period
- 2020
- Total Assets
- 1383.69
- Total Liabilities
- 771.64
- Total Equity
- 612.05
- Tangible Book Valueper Share Common Eq
- 154.84
- Period
- 2020
- Cashfrom Operating Activities
- 247.23
- Cashfrom Investing Activities
- -205.72
- Cashfrom Financing Activities
- 26.97
- Net Changein Cash
- 68.49
- Period
- 2019
- Total Revenue
- 1341.04
- Selling/ General/ Admin Expenses Total
- 204.58
- Depreciation/ Amortization
- 46.85
- Other Operating Expenses Total
- 14.87
- Total Operating Expense
- 1165.73
- Operating Income
- 175.31
- Net Income Before Taxes
- 151.56
- Net Income
- 94.24
- Diluted Normalized EPS
- 23.85
- Period
- 2019
- Total Assets
- 1425.69
- Total Liabilities
- 850.03
- Total Equity
- 575.66
- Tangible Book Valueper Share Common Eq
- 145.14
- Period
- 2019
- Cashfrom Operating Activities
- 20.96
- Cashfrom Investing Activities
- -138.54
- Cashfrom Financing Activities
- 121.72
- Net Changein Cash
- 4.14
- Period
- 2018
- Total Revenue
- 1039.51
- Selling/ General/ Admin Expenses Total
- 182.49
- Depreciation/ Amortization
- 43.31
- Other Operating Expenses Total
- 8.92
- Total Operating Expense
- 952.57
- Operating Income
- 86.94
- Net Income Before Taxes
- 78.96
- Net Income
- 53.34
- Diluted Normalized EPS
- 13.66
- Period
- 2018
- Total Assets
- 1052.91
- Total Liabilities
- 564.54
- Total Equity
- 488.38
- Tangible Book Valueper Share Common Eq
- 127.7
- Period
- 2018
- Cashfrom Operating Activities
- 106.61
- Cashfrom Investing Activities
- -81.25
- Cashfrom Financing Activities
- -20.07
- Net Changein Cash
- 5.29
- Period
- 2017
- Total Revenue
- 636.19
- Selling/ General/ Admin Expenses Total
- 110.89
- Depreciation/ Amortization
- 26.83
- Other Operating Expenses Total
- 6.09
- Total Operating Expense
- 594
- Operating Income
- 42.2
- Net Income Before Taxes
- 35.56
- Net Income
- 27.12
- Diluted Normalized EPS
- 8.86
- Period
- 2017
- Total Assets
- 939
- Total Liabilities
- 499.49
- Total Equity
- 439.51
- Tangible Book Valueper Share Common Eq
- 115.56
- Period
- 2017
- Cashfrom Operating Activities
- 163.12
- Cashfrom Investing Activities
- -66.88
- Cashfrom Financing Activities
- -89.47
- Net Changein Cash
- 6.78
- Period
- 2022-12-31
- Total Revenue
- 419.84
- Selling/ General/ Admin Expenses Total
- 56.75
- Depreciation/ Amortization
- 29.62
- Other Operating Expenses Total
- 55.92
- Total Operating Expense
- 397.48
- Operating Income
- 22.36
- Net Income Before Taxes
- 8.24
- Net Income
- 5.64
- Diluted Normalized EPS
- 1.46
- Period
- 2022-12-31
- Period
- 2022-12-31
- Period
- 2022-09-30
- Total Revenue
- 400.46
- Selling/ General/ Admin Expenses Total
- 20.41
- Depreciation/ Amortization
- 25.85
- Other Operating Expenses Total
- 101.72
- Total Operating Expense
- 383.03
- Operating Income
- 17.43
- Net Income Before Taxes
- 11.3
- Net Income
- 7.9
- Diluted Normalized EPS
- 2.04
- Period
- 2022-09-30
- Total Assets
- 2477.27
- Total Liabilities
- 1640.72
- Total Equity
- 836.55
- Tangible Book Valueper Share Common Eq
- 210.93
- Period
- 2022-09-30
- Cashfrom Operating Activities
- -117.33
- Cashfrom Investing Activities
- -88.34
- Cashfrom Financing Activities
- 209.68
- Net Changein Cash
- 4.38
- Period
- 2022-06-30
- Total Revenue
- 388.81
- Selling/ General/ Admin Expenses Total
- 21.06
- Depreciation/ Amortization
- 21.67
- Other Operating Expenses Total
- 81.98
- Total Operating Expense
- 351.9
- Operating Income
- 36.9
- Net Income Before Taxes
- 30.23
- Net Income
- 22.36
- Diluted Normalized EPS
- 5.74
- Period
- 2022-06-30
- Period
- 2022-06-30
- Period
- 2022-03-31
- Total Revenue
- 376.85
- Selling/ General/ Admin Expenses Total
- 20.45
- Depreciation/ Amortization
- 19.97
- Other Operating Expenses Total
- 90.05
- Total Operating Expense
- 336.59
- Operating Income
- 40.26
- Net Income Before Taxes
- 40.67
- Net Income
- 29.91
- Diluted Normalized EPS
- 5.28
- Period
- 2022-03-31
- Total Assets
- 2176.03
- Total Liabilities
- 1363.77
- Total Equity
- 812.26
- Tangible Book Valueper Share Common Eq
- 204.19
- Period
- 2022-03-31
- Cashfrom Operating Activities
- 4.74
- Cashfrom Investing Activities
- -320.45
- Cashfrom Financing Activities
- 332.91
- Net Changein Cash
- 17.07
- Period
- 2021-12-31
- Total Revenue
- 394.54
- Selling/ General/ Admin Expenses Total
- 18.56
- Depreciation/ Amortization
- 18.14
- Other Operating Expenses Total
- 84.88
- Total Operating Expense
- 365.01
- Operating Income
- 29.53
- Net Income Before Taxes
- 33.8
- Net Income
- 24.95
- Diluted Normalized EPS
- 6.79
- Period
- 2021-12-31
- Period
- 2021-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Technical
Moving Average
SMA
- 5 Day996.51
- 10 Day1021.55
- 20 Day1068.68
- 50 Day1127.84
- 100 Day1243.24
- 300 Day1286.26
Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Meghmani Finechem
- 1033.5
- 1.1
- 0.11
- 1736.6
- 741.1
- 4307.51
- Rallis India
- 205.6
- 0.45
- 0.22
- 289.15
- 182.55
- 3984.67
- Privi Speciality Chemicals
- 912
- -63.05
- -6.47
- 2193.8
- 957.45
- 3818.57
- Rossari Biotech
- 687
- -3.4
- -0.49
- 1250
- 675
- 3807.66
- Bharat Rasayan
- 9025.25
- -4.1
- -0.05
- 14362.9
- 9001
- 3771.09
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Meghmani Finechem
- 17.04
- 5.93
- -
- -
- Rallis India
- 23.24
- 2.35
- 13.09
- 8.11
- Privi Speciality Chemicals
- 40.84
- 4.7
- 16.8
- 7.95
- Rossari Biotech
- 41.09
- 4.72
- 23.46
- 8.71
- Bharat Rasayan
- 21.07
- 4.9
- 28.48
- 13.07
Shareholding
- Category
- Percentage
- No. of shares
- Public Shareholding
- 25.95%
- 10,137,105
- Banbridge Limited
- 6.1%
- 2,383,958
- Overseas Corporate Bodies
- 6.1%
- 2,383,958
- Director or Director's Relatives
- 1.88%
- 734,980
- Rajesh Harichandra Budhrani
- 1.82%
- 712,480
- HUF
- 0.52%
- 201,194
- LLP
- 0.09%
- 33,973
- Trusts
- 0.02%
- 6,772
- Clearing Members
- 0.01%
- 4,635
- Others
- 7.22%
- 2,819,190
- Others
- 4.32%
- 1,688,162
- SBI Large & Midcap Fund
- 1.65%
- 644,538
- Axis Mutual Fund Trustee Limited A/c Axis Mutual Fund A/c Axis Growth Opprtunities Fund
- 1.36%
- 532,024
- Others
- 0.02%
- 6,672
- Others
- 0.76%
- 297,391
- Others
- 0.69%
- 268,965
- Others
- 0.57%
- 222,599
- Others
- 0.57%
- 221,246
- Others
- 0.18%
- 70,806
- Promoter & Promoter Group Shareholding
- 74.05%
- 28,925,601
- Vivira Investment & Trading Private Limited
- 39.67%
- 15,495,188
- Moneymart Securities Private Limited
- 8.74%
- 3,412,502
- MM Infra & Leasing Private Limited'
- 0.2%
- 79,758
- Mahesh P Babani
- 6.62%
- 2,586,348
- Mahesh Purshottam Babani HUF
- 4.59%
- 1,791,720
- Bhaktavatsala Rao Doppalapudi
- 3.96%
- 1,548,202
- Vinaykumar Doppalapudi Rao
- 2.28%
- 891,068
- Vijaykumar Doppalpudi
- 2.19%
- 855,006
- Premaleela Doppalapudi
- 1.34%
- 524,522
- Jyoti Mahesh Babani
- 1%
- 390,000
- Seema Mahesh Babani
- 1%
- 390,000
- Snehal Mahesh Babani
- 1%
- 390,000
- Sharon Doppalapudi
- 0.63%
- 245,656
- Grace Vinay Kumar Doppalapudi
- 0.59%
- 232,185
- Rameshbabu Gokarneswararao Guduru'
- 0.24%
- 93,446
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 02-Feb-23
- Quarterly Results
- 07-Nov-22
- Quarterly Results
- 10-Aug-22
- Quarterly Results
- 05-May-22
- Audited Results & Final Dividend
- 27-Jan-22
- Quarterly Results
- 01-Nov-21
- Quarterly Results
- 29-Jul-21
- Quarterly Results
- 14-May-21
- Audited Results & Final Dividend
- 05-Feb-21
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 28-Sept-22
- 05-May-22
- AGM
- 27-Aug-21
- 17-May-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 05-May-22
- 21-Sept-22
- 20-Sept-22
- 2
- 14-May-21
- 18-Aug-21
- 17-Aug-21
- 2
No recent bonus announcements.
No recent splits available.
No recent rights issue declared.
Company Profile
ABOUT Privi Speciality Chemicals
- Industry Chemical Manufacturing
- ISIN INE959A01019
- BSE Code 530117
- NSE Code PRIVISCL
Privi Speciality Chemicals Limited is an India-based company manufacturer, supplier, and exporter of aroma and fragrance chemicals. The Company’s Aroma Chemicals include Alpha Damascone, Alpha Ionone Pure, Alpha Ionone, Alpha Ionone, Alpha Terpenyl Acetate, Amber Fleur, Amber Gamma, Beta Iso Damascol, BI Perfumery Grade, BI Technical Grade, Cedar Ketol, Citronellal, Citronellyl Acetate, Citronellyl Nitrile, Dipentene, Dihydro Myrcenol, Dihydromyrcene Extra Pure, Gamma Methyl Ionone, Gamma Terpinyl Acetate, Geraniol, Geranyl Acetate, Indian Sandal Core, Iso Boronyl Acetate, L-Limonene, Methyl Ionone, Nerol, Neryl Acetate, Nimberol, OTBCHA, Pine-Oil-20, Pine-Oil-85, Prionyl, PTBCH, Sandal Fleur, Terpeniol Alpha, Terpeniol Gamma, Terpineol BP Grade, Terpinolene-40, Tetrahydroflorol, Tetrahydrogeraniol, Tetrahydrogeranyl Acetate, Tetrahydromyrcenol, Timber Forte and Timber Touch. The Company is also developing Carvacrol, Terpinene-4-OL and 1,8, Cineol (Eucalyptol) products.
MANAGEMENT
- Mahesh Babani Executive Chairman of the Board, Managing Director
- R. Rajan President
- Narayan Iyer Chief Financial Officer
- Ashwini Shah Compliance Officer, Company Secretary
- Bhaktavatsala Doppalapudi Executive Director
Company Summary
PRIVI SPECIALITY CHEMICALS SUMMARY
Privi Speciality Chemicals is trading 6.47% lower at Rs 912.00 as compared to its last closing price. Privi Speciality Chemicals has been trading in the price range of 990.0 & 892.0. Privi Speciality Chemicals has given -14.5% in this year & -3.89% in the last 5 days.
Privi Speciality Chemicals has TTM P/E ratio 67.66 as compared to the sector P/E of 13.54. There are 1 analysts who have initiated coverage on Privi Speciality Chemicals. There are 0 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.
The company posted a net profit of 5.64 Crores in its last quarter.
Listed peers of Privi Speciality Chemicals include Meghmani Finechem (0.11%), Rallis India (0.22%), Privi Speciality Chemicals (-6.47%) etc.
Privi Speciality Chemicals has a 74.05% promoter holding & 25.95% public holding.
FAQs about Privi Speciality Chemicals
Privi Speciality Chemicals is trading at 912.00 as on 6 Feb, 2023 3:29:07 PM. This is -6.47% lower as compared to its previous closing price of 975.05
The market capitalization of Privi Speciality Chemicals is 3818.58 Cr as on 6 Feb, 2023 3:29:07 PM.
The average broker rating on Privi Speciality Chemicals is Buy. The breakup of analyst rating is given below -
- 0 analysts have given a strong sell rating
- 0 analysts have given a sell rating
- 0 analysts have given a hold rating
- 1 analysts have given a buy rating
- 0 analysts have given a strong buy rating
The 52 wk high for Privi Speciality Chemicals is 2193.8 whereas the 52 wk low is 957.45
Privi Speciality Chemicals can be analyzed on the following key metrics -
- TTM P/E: 67.66
- Sector P/E: 13.54
- Dividend Yield: 0.2%
- D/E ratio: -
Privi Speciality Chemicals reported a net profit of 97.38 Cr in 2022.
